Regeneron and Sanofi Announce Positive Dupixent® (dupilumab) Phase 3 Atopic Dermatitis Data Published in the New England Journal of Medicine
Go back to Regeneron and Sanofi Announce Positive Dupixent® (dupilumab) Phase 3 Atopic Dermatitis Data Published in the New England Journal of Medicine| Regeneron (NASDAQ: REGN) | Delayed: 803.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $803.48 | 52 Week High | $592.36 | |||
| Open | $803.48 | 52 Week Low | $325.35 | |||
| Day High | $803.48 | P/E | 210.89 | |||
| Day Low | $803.48 | EPS | $3.81 | |||
| Volume | 158 | |||||
| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 14.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.76 | 52 Week High | $5.58 | |||
| Open | $14.76 | 52 Week Low | $3.60 | |||
| Day High | $14.76 | P/E | N/A | |||
| Day Low | $14.76 | EPS | $0.00 | |||
| Volume | 83,906 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 43.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.72 | 52 Week High | $44.76 | |||
| Open | $43.72 | 52 Week Low | $36.81 | |||
| Day High | $43.72 | P/E | N/A | |||
| Day Low | $43.72 | EPS | $0.00 | |||
| Volume | 10,000 | |||||
